IS-free Treg Stem Cell Transplant
A Pilot/Phase 1 Study of Immunosuppression-free Regulatory T-cell Graft-engineered Haploidentical Hematopoietic Cell Transplantation in Relapsed/Refractory AML/MDS
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 10 patients (estimated)
- Sponsors
- Dana-Farber Cancer Institute
- Tags
- Adoptive Cellular Therapy, Allogeneic Stem Cell Transplant, Chemotherapy, T Cell (Allogeneic), CD34, Radiation Therapy
- Trial Type
- Treatment
- Last Update
- 1 month ago
- SparkCures ID
- 1598
- NCT Identifier
- NCT04678401
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.